The beauty divisions of Givaudan, dsm-firmenich, IFF and Symrise delivered a weighted average organic growth of 5.2% in H1 2026 and accelerated in Q2 to 6.7%. Fine fragrance remained an important growth engine overall.
Givaudan’s Fragrance & Beauty generated sales €2,140m in H1, up 6.5% at constant rates. Growth reached 7.1% Q2 driven by Consumer Products. Fine Fragrance also continued to grow despite a demanding comparison base, but Fragrance Ingredients and Active Beauty continued to decline.
At dsm-firmenich, Perfumery & Beauty grew 7.0% at constant rates in both H1 and Q2, reaching respectively €1,948m and €981m. Growth was driven by volume notably in Fine Fragrances and Consumer Fragrances. Ingredients also improved and were stable in Q2. A strong performance in June led the group to raise its full-year outlook to the upper end of its target range.
IFF sales grew 4.5% at constant rates in H1 but accelerated to 7.8% in Q2. New wins and higher volumes boosted Fragrance Ingredients and Consumer Fragrance, while Fine Fragrance also grew despite the conflict in the Middle East.
Symrise’s Scent & Care division returned to growth in Q2 with an ultimately flat first half. Q2 sales rose 3.8% organically to €509m driven by Consumer Fragrance and Aroma Molecules. Care & Wellness was still impacted by weak demand for UV filters, while Fine Fragrance faced a high comparison base.
The smaller fragrance houses also reported strong growth, although the way they disclose their results is less directly comparable. Takasago’s Fragrance sales rose 12.8% in H1 and 22.2% in Q2 on a reported basis, supported by Fine Fragrance in Europe and Home and Fabric Care in Southeast Asia and China.
Robertet’s Fragrance division grew 12.6% organically in H1 to €176m, led by niche Fine Fragrance brands and new entrants in the fragrance category. The company did not disclose a separate Q2 figure.
